Status:
ACTIVE_NOT_RECRUITING
Prospective Cohort Study of a Population at Risk of Psychotic Transition
Lead Sponsor:
Centre Hospitalier Esquirol
Conditions:
At-risk Mental States
Eligibility:
All Genders
15-30 years
Brief Summary
In psychiatry, insight is the patient's awareness of his or her disorder or symptom. Lack of insight also seems to be associated with the presence of anxiety-depressive symptoms. There are several fo...
Eligibility Criteria
Inclusion
- Male or female ;
- Be aged between 15 and 30 ;
- Being assessed by the eDIP (early intervention team "équipe de détection et d'intervention précoce") ;
- Sufficient level of French to understand and express yourself orally and in writing;
- For adults:
- Patients who have received informed information about the study and who have signed a consent to participate in the study;
- \- For minors: Patient who has received informed information about the study and who has signed, as well as the holders of parental authority the minor's consent to participate in the study.
Exclusion
- Have already presented a First Psychotic Episode;
- Previous diagnosis of schizophrenia, psychotic disorder or bipolar disorder;
- Being on antipsychotic treatment at the time of inclusion ;
- Known intellectual disability ;
- Pregnant or breast-feeding woman;
- Minors and adults under legal protection.
Key Trial Info
Start Date :
November 18 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2030
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06539611
Start Date
November 18 2024
End Date
March 1 2030
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mirvat B HAMDAN-DUMONT
Limoges, France, 87025